JACARDI logo

JACARDI seeks to reduce the burden of non-communicable diseases (NCDs) such as cardiovascular diseases and diabetes by increasing awareness of related risks and the acceptance of innovative lifestyle interventions. JACARDI plans to implement 142 pilots that will reach and improve the care of millions of people in Europe.

JACARDI aims to create a more equitable and sustainable healthcare system across Europe by establishing a common methodology and harmonizing procedures for the implementation of the pilot studies. This will also help demonstrate the scalability of interventions for NCDs.

By working with 21 European countries, JACARDI will also ensure diversity in terms of cultural backgrounds, public health priorities, and healthcare systems. Wide geographical coverage and extensive pilot implementations are expected to provide a wealth of data for mutual learning and the identification of successful practices.

Objectives

  • Enhance health literacy and raise awareness about cardiovascular disease (CVD) and diabetes among the general population.
  • Implement effective primary prevention measures, screening and improved care pathways for CVD and diabetes among high-risk groups.
  • Enhance self-management support, and labour market participation for individuals diagnosed with CVD and diabetes.
  • Improve data availability, quality, and accessibility across the patient journey.
  • Promote equity in access to healthcare services and information, ensuring that everyone has equal opportunities regardless of language proficiency, abilities, age, or life situation.

CHEPI involvement:

CHEPI will be supporting work package 5 (WP5) in JACARDI: Methodological framework and integrative approach听for technical WPs, pilots鈥� implementations and assessment and inclusion of transversal and intersectional aspects.

In particular, CHEPI will be working with Bocconi University to deliver task 5.6.3. This will use the Health-GPS policy simulation tool to estimate the longer-term health and economic outcomes of selected pilot studies.

Principal investigator:听Dr Benedetta Armocida (ISS)

CHEPI Lead:听Professor Franco Sassi

贵耻苍诲别谤:听European Commission (Joint Action)

笔补谤迟苍别谤蝉:听ISS, Sciensano,听Ministry of Health of the Republic of Cyprus, HZJZ, THL, SZU,听Agence Nationale de Sante Publique,听Ministry of Health Greece,听Semmelweis Egyetem,听Landlaeknis Embaettid, HSE Ireland, SPKC,听Higienos Institutas,听Ministry for Health Malta,听Helsedirektoratet,听Uniwersytet Medyczny im Karola Marcinkowskieg,听Ministerio da Saude Portugal,听Institutul National de Sanatate Publica, NIJZ, Vicepresidencia Segunda y Consejeria de Sanidad y Servicios Sociales,听State Institution Public Health Center Ukraine

Duration: November 2023 - November 2027听(48 months)

奥别产蝉颈迟别:听

听

听